We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
(+14%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.3
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$269M |
| 2 |
Stericycle Inc
SRCL
|
+$141M |
| 3 |
Marathon Oil Corporation
MRO
|
+$108M |
| 4 |
ChampionX
CHX
|
+$103M |
| 5 |
Spirit AeroSystems
SPR
|
+$95.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitrans Midstream Corporation Common Stock
ETRN
|
+$149M |
| 2 |
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.8M |
| 3 |
Southwestern Energy Company
SWN
|
+$56.7M |
| 4 |
Union Pacific
UNP
|
+$24.2M |
| 5 |
US Steel
X
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.91% |
| 2 | Technology | 19.62% |
| 3 | Healthcare | 14.36% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
| $4.75K | ﹤0.01% |
47,479
-1,534
| -3% | -$164 |
2022 Q1
10 quarters
|
|
477
CALL
BioMarin Pharmaceuticals
BMRN
$10.6B
| $4.13K | ﹤0.01% |
15,000
-25,000
| -63% | -$2.09M |
2023 Q4
3 quarters
|
|
478
Roadzen Inc Warrants
RDZNW
| $4.11K | ﹤0.01% |
65,696
-1,485
| -2% | -$113 |
2022 Q2
9 quarters
|
|
479
Royalty Management Holding Warrant
RMCOW
| $3.68K | ﹤0.01% |
221,686
-4,893
| -2% | -$82 |
2024 Q2
1 quarter
|
|
480
CALL
Novo Nordisk
NVO
$171B
| $3.63K | ﹤0.01% |
25,000
-10,000
| -29% | -$1.33M |
2024 Q1
2 quarters
|
|
481
CALL
Schrodinger
SDGR
$2.04B
| $3K | ﹤0.01% |
30,000
-40,000
| -57% | -$822K |
2024 Q2
1 quarter
|
|
482
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
| $2.39K | ﹤0.01% |
127,590
-2,816
| -2% | -$51 |
2021 Q4
11 quarters
|
|
483
Syntec Optics Holdings Warrant
OPTXW
$27.4M
| $2.32K | ﹤0.01% |
32,034
-1,035
| -3% | -$112 |
2022 Q1
10 quarters
|
|
484
CALL
GSK
GSK
$93.2B
| $2.25K | ﹤0.01% |
30,000
-40,000
| -57% | -$1.64M |
2024 Q2
1 quarter
|
|
485
Tevogen Inc Warrant
TVGNW
$1.25M
| $2.19K | ﹤0.01% |
181,387
-4,029
| -2% | -$79 |
2022 Q1
10 quarters
|
|
486
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
| $2.16K | ﹤0.01% |
76,252
-2,464
| -3% | -$249 |
2023 Q4
3 quarters
|
|
487
PUT
UGI
UGI
$7.96B
| $1.79K | ﹤0.01% |
71,700
| – | – |
2024 Q2
1 quarter
|
|
488
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
| $1.77K | ﹤0.01% |
133,215
-2,940
| -2% | -$121 |
2022 Q1
10 quarters
|
|
489
PUT
Vistra
VST
$54.2B
| $698 | ﹤0.01% |
27,900
| – | – |
2024 Q1
2 quarters
|
|
490
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
| $257 | ﹤0.01% |
17,995
-397
| -2% | -$6 |
2023 Q1
6 quarters
|
|
491
Airbnb
ABNB
$97.8B
| – | – |
-22,500
| Closed | -$3.41M | – |
|
492
American Electric Power
AEP
$66.9B
| – | – |
-91,000
| Closed | -$7.98M | – |
|
493
CALL
Alnylam Pharmaceuticals
ALNY
$31.1B
| – | – |
-10,000
| Closed | -$46K | – |
|
|
494
PUT
Alnylam Pharmaceuticals
ALNY
$31.1B
| – | – |
-19,100
| Closed | -$27.9K | – |
|
495
Air Products & Chemicals
APD
$62.6B
| – | – |
-44,500
| Closed | -$11.5M | – |
|
496
Amphenol
APH
$215B
| – | – |
-378,200
| Closed | -$12.7M | – |
|
497
PUT
Ardelyx
ARDX
$847M
| – | – |
-100,000
| Closed | -$37.5K | – |
|
498
ASML
ASML
$684B
| – | – |
-2,863
| Closed | -$2.93M | – |
|
499
CALL
Axsome Therapeutics
AXSM
$8.82B
| – | – |
-15,000
| Closed | -$46.9K | – |
|
500
DELISTED
The AZEK Co
AZEK
| – | – |
-133,200
| Closed | -$5.61M | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2024 Portfolio in Review
As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.
- UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
- UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
- UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
- UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
- UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
- UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.
Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.